In a recent analysis of eight GWAS datasets with 17,153 cases and 239,337 controls by Yuan et al. [92], at least six HCP5 SNVs (including rs3130907 within the HCP5 sequence) were associated significantly with lung cancer susceptibility along with the novel risk SNV rs114020893 in the lncRNA NEXN-AS1 region at 1p31.1. This evidence concerns the gene HCP5 and lung carcinoma.